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Editor: Jay GanPlants, animals and humans, are colonized bymicroorganisms (microbiota) and transiently exposed to countless
others. The microbiota affects the development and function of essentially all organ systems, and contributes to
adaptation and evolution, while protecting against pathogenic microorganisms and toxins. Genetics and lifestyle
factors, including diet, antibiotics and other drugs, and exposure to the natural environment, affect the composi-
tion of the microbiota, which inﬂuences host health through modulation of interrelated physiological systems.
These include immune system development and regulation, metabolic and endocrine pathways, brain function. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1019L. Flandroy et al. / Science of the Total Environment 627 (2018) 1018–1038and epigeneticmodiﬁcation of the genome. Importantly, parentalmicrobiotas have transgenerational impacts on
the health of progeny.
Humans, animals and plants share similar relationships with microbes. Research paradigms from humans and
other mammals, amphibians, insects, planktonic crustaceans and plants demonstrate the inﬂuence of environ-
mental microbial ecosystems on the microbiota and health of organisms, and indicate links between environ-
mental and internal microbial diversity and good health. Therefore, overlapping compositions, and
interconnected roles of microbes in human, animal and plant health should be considered within the broader
context of terrestrial and aquaticmicrobial ecosystems that are challenged by the human lifestyle and by agricul-
tural and industrial activities.
Here, we propose research priorities and organizational, educational and administrative measures that will help
to identify safe microbe-associated health-promoting modalities and practices. In the spirit of an expanding ver-
sion of “One health” that includes environmental health and its relation to human cultures and habits
(EcoHealth), we urge that the lifestyle-microbiota-human health nexus be taken into account in societal decision
making.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Animals and plants harbor very diverse and abundant microbial
communities that provide speciﬁc functions and traits. These communi-
ties are calledmicrobiotawhen referring to the ecological community of
microorganisms within a deﬁned environment, or microbiome when
referring to the collective genomes of all microorganisms from a given
environmental niche. A recent workshop (Workshop Session, 2016b)discussed correlations between disturbed gut microbiota (dysbiosis)
and chronic pathologies (non-communicable diseases – NCDs) includ-
ing allergies (Fujimura and Lynch, 2015; Hua et al., 2016), autoimmu-
nity (Chen et al., 2016), gastrointestinal disorders (Cenit et al., 2015),
obesity, diabetes (Cani et al., 2014; de Goffau et al., 2013; Knip and
Siljander, 2016), and other metabolic and cardiovascular disorders
(Tang and Hazen, 2014), cancer (Poutahidis et al., 2015), and central
nervous systemdysfunctions such as learning andmemory impairment,
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andHsiao, 2017). A linkwith themicrobiota has also been suggested for
neurodegenerative disorders like Alzheimer's disease (Fox et al., 2013).
Research in this area has focused mostly on the interactions with
host health of the intestinal microbiota. This is viewed as a paradigm
for exploring the whole body microbiota, including that of skin
(Fyhrquist et al., 2014), respiratory (Yu et al., 2015), and reproductive
systems and upper gastrointestinal tract. It is recognized that inﬂamma-
tion, whether chronic or acute, is a common pathogenetic link between
the disturbed gutmicrobiota and theNCDsmentioned above. For exam-
ple, this is true for asthma, linked to the impact of themicrobiota on the
respiratory tract (Rook et al., 2004), and for arthritis (Scher et al., 2013),
and for inﬂammation in the pancreas leading to Type 1 diabetes (Knip
and Siljander, 2016). This suggests that the immune system has a cen-
tral role in the axis connecting the gut microbiota to tissue damage lo-
cated distant from the gut (Rao et al., 2007; Round and Mazmanian,
2009), but most, perhaps all physiological systems are involved, as
discussed below.
It should be noted that deﬁning a general “health-promoting” versus
“disease-predisposing” gut microbiota is difﬁcult, since it may depend
on various factors such as age, geographical situation, diet, and genetics.
Moreover, the resultingmetabolomemight bemore important than the
underlying community structure (Maurice et al., 2013; O'Keefe et al.,
2015). More needs to be learnt about the normal variability of the
human intestinal microbiota and the factors that determine it. At pres-
ent, a disturbed microbiota can only be deﬁned by comparison with
an average “normal” microbiota in a given population (Falony et al.,
2016; Raes, 2016), and perhaps only at the level of the individual
(Zeevi et al., 2015).Fig. 1.A summary of themain issues. Themicrobial world inﬂuences humanwellbeing directly v
quality, climate and the environment. Human activities are depleting and distorting the over
community composition of the microbiota. The consequences for human health are likely to
and metabolic disorders that are at least partly attributable to distortions of human or environThe Environmental and internal microbiome session of the workshop
mentioned above aimed at opening a window on the microbiota in a
OneHealth/EcoHealth perspective, leaning on their potential ecosystem
services for human and environment health and on their potential dis-
turbance by various factors (Fig. 1). The objective of this review
(which expands the original workshopwith additional authors andma-
terial) is to explore these issues in the broader context of the
microbiotas of animals, plants, soil and the natural environment, with
particular emphasis on the parallels between the compositions and
functions of these different microbiotas, and the crucial links between
these natural compartments. We also discuss the ways in which
human activities are distorting these microbiotas and creating risks to
human, animal and plant health. Finally, we suggest research priorities,
and propose administrative and educational measures that can help to
stop this damage to our microbial environment.
2. Microbiota and health
2.1. Lessons learnt from studies on humans and animals
Germ free mouse models have demonstrated that microbiota can
play a role in the prevention or causation of several of the pathologies
mentioned above (Noval Rivas et al., 2013; Turnbaugh et al., 2006;
Wu et al., 2010) and (workshop presentations by Clarke, 2016; Dao,
2016; Plovier, 2016; Poutahidis, 2016). Similarly, introducing certain
bacterial species or cocktails into the gut microbiota of mouse models
can improve their health ormake sensitive strainsmore resistant to dis-
ease than controls (Bravo et al., 2011; Forsythe et al., 2007; Poutahidis et
al., 2013b). Thirdly, when germ free mice are colonized with theia effects on humandevelopment, physiology and health, and indirectly via effects on food
lapping microbiota in all these domains. This has a substantial effect on the genetic and
be severe. Already we are seeing increases in non-communicable inﬂammatory diseases
mental microbiota.
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ing humans, they recapitulate features of the donor disease (Collins,
2016; Ridaura et al., 2013; Zheng et al., 2016) and (workshop presenta-
tions by Clarke, 2016; Dao, 2016; Plovier, 2016; Poutahidis, 2016).
However, data from experiments on animals cannot easily be trans-
lated to humans (Kelly et al., 2016; Nguyen et al., 2015). Somemicrobial
strains or cocktails were shown to have different effects in different an-
imal species. The parameters that control the microbiota of each indi-
vidual are complex and not fully understood. Under different
laboratory and animal housing conditions, the replication of supposedly
similar experiments do not always give the same results (Franklin and
Ericsson, 2017).
Importantly, several speciﬁc bacterial strains of the species
Akkermansia muciniphila (Dao et al., 2016; Derrien et al., 2017;
Everard et al., 2013), Bacteroides uniformis (Gaufﬁn Cano et al., 2012),
Lactobacillus reuteri (Poutahidis et al., 2013a), L. rhamnosus, and L.
johnsonii, among others, have been associated with positive health ef-
fects in animals and to a lesser extent in humans (Agustina et al.,
2013; Agustina et al., 2012) (also discussed in workshop presentations
by Clarke, 2016; Dao, 2016; Plovier, 2016; Poutahidis, 2016). Therapeu-
tic potential of manipulating the microbiota is discussed in a later
section.
2.2. Mechanisms of health beneﬁts
The precise mechanisms that enable a beneﬁcial gut microbiota to
prevent NCDs remain to be fully characterized, although some impor-
tant aspects of this phenomenon have been elucidated, and common
patterns of action start to be understood.
2.2.1. Regulation of immune and endocrine systems
Severalmetabolites and structural components of a healthymicrobi-
ota behave as biologically activemolecules that interact with physiolog-
ical pathways of the host (workshop presentations by Clarke, 2016; Dao,
2016; Plovier, 2016; Poutahidis, 2016), to regulate organ development
(including the brain) (Cryan and Dinan, 2012; McFall-Ngai et al.,
2013), metabolism (Canfora et al., 2015), and immunoregulation (Tan
et al., 2016; Zeng and Chi, 2015). These active bacterial molecules in-
clude short-chain fatty acids (SCFA) andmetabolites of tyrosine or tryp-
tophan that play important roles as modulators of both immune and
neuroendocrine systems. They have been shown to upregulate regula-
tory T lymphocytes, downregulate pro-inﬂammatory cytokine produc-
tion, and induce hormonal secretion (serotonin, oxytocin, indole
derivatives - exerting anti-inﬂammatory effect on the CNS - T4 hor-
mone, testosterone) in relation to anti-inﬂammatory effects (Erdman
and Poutahidis, 2016; Poutahidis et al., 2013a, 2014; Varian et al.,
2016; Yano et al., 2015). Overall, those microbial products activate in-
terrelated immune, endocrine and central nervous system pathways
that counteract NCDs (Carabotti et al., 2015; Marsland, 2016; Moloney
et al., 2014). Importantly, keeping a healthy immune, metabolic and
neuroendocrine proﬁlemay be important for preventing cancer. Indeed,
it is strongly suggested that interactions between immune system func-
tion, hormones, and psychosomatic factors could determine whether
pre-neoplastic lesions progress towards cancer (Erdman and
Poutahidis, 2015; Poutahidis and Erdman, 2016).Moreover, sex steroids
are conjugated in the liver, and then secreted into the gut with the bile.
The gut microbiota then deconjugates these steroids, which allows
them to be re-absorbed (conjugated forms are mostly lost in the
feces). But themicrobiota alsomodiﬁes the sex steroids so that the pro-
ﬁle of metabolites that is reabsorbed depends on the nature of the mi-
crobiota. Among other potential effects, it is suggested that this
variable metabolite proﬁle modulates cancer risk in post-menopausal
women (Adlercreutz et al., 1976; Fuhrman et al., 2014).
Maintenance of an intact gut barrier function may also be crucial for
reducing disease risk. Optimal gut barrier function depends on several
components such as secretory IgA and selective paracellularpermeability. A recent study focused on inducers of gut mucosal IgA
production, and its levels in relation to the transition from breast feed-
ing tomore diverse diets (Planer et al., 2016). Disruption of the gut bar-
rier leading to increased intestinal permeability facilitates the
translocation of immunogenic (bacterial) components beyond the gut.
This is linked to various NCDs and has been speciﬁcally suggested to
trigger systemic inﬂammation and favor distal cancer development
(Erdman and Poutahidis, 2015).
Heat-killed forms of some microbes retain their ability to induce
positive effects on our physiology through interactionwith the immune
system and anti-inﬂammatory effects (Reber et al., 2016; Ruiz et al.,
2014; Varian et al., 2017). Therefore, structural bacterial components
with health-promoting effects (called postbiotics) could hold promise
as they can be present in regimens containing non-viable bacterial
cells (Adams, 2010; Plovier et al., 2017).
This phenomenon is not restricted to the gastro-intestinal tract. In-
terestingly, living bacteria or bacterial components that we breathe in
the environment/green spaces and inhale into our upper respiratory
tract have been shown to have anti-inﬂammatory effects similar to
those of living beneﬁcial gut microbes (Schuijs et al., 2015). The lipo-
polysaccharides (LPS) from Gram-negative bacterial membranes may
have anti-inﬂammatory effects on lung epithelium by reducing the pro-
duction of inﬂammatory cytokines involved in allergy. This occurs after
repeated low dose exposure, via the mechanisms of “endotoxin toler-
ance”. These LPS components also have similar effects on the intestinal
epithelium. But interestingly, the molecular structure of LPS varies be-
tween bacterial strains and this variation can modify the immunomod-
ulatory effect. This can explain a higher incidence of auto-immune
diseases in different countries/regions, due to prevalent exposure to dif-
ferent bacterial strains and their variant LPS (Vatanen et al., 2016).
Other bacterial components or metabolites modulate the immune sys-
tem via the arylhydrocarbon receptor (Zelante et al., 2014), respiratory
neuroendocrine cells (Branchﬁeld et al., 2016), toll-like receptors and
other cellular sensory systems (Moore, 2015).2.2.2. Educating immune system memory
The previous paragraphs concentrate on the immunoregulatory sig-
nals derived from microbial exposures. However, as far as the immune
system is concerned, exposure to a wide diversity of microorganisms
does more than merely set up immunoregulatory circuits. The immune
system at birth resembles a computer with hardware and software, but
almost no data. The necessary data are providedmostly by microorgan-
isms that increase the repertoire ofmemory T lymphocytes. But because
all life formsultimately sharemany structures and genes, thesememory
cells, evenwhen driven by harmless environmental species, can include
cells that recognize pathogens. For example, HIV-1-speciﬁc CD4+ T cells
are abundant in the blood of seronegative donors. These cells have the
typical properties of memory T cells, and were shown to cross-react
with other organisms from the environment (Su et al., 2013). Thus, in
addition to priming immunoregulatory circuits, exposure to microbial
biodiversity provides crucial data that builds up the antigenic repertoire
of the immune system. This repertoire is clearly relevant to eventual at-
tack responses against pathogens, but also contributes to the develop-
ment of a repertoire of tolerated bacteria, foods and environmental
molecules. Lack of priming through external antigens could compro-
mise this part of development and contribute to auto-immune and al-
lergic diseases.
Ensuring long term contributions of the various microbiota (gut,
skin, month, vaginal, respiratory tract) to good health may require
more than transient enrichment with speciﬁc microbes, metabolites
or components. Good health may require continuous cross-talk
between the host and the microbiota in a symbiotic relationship
(Everard et al., 2013), which needs to be characterized better. This
includes a better understanding of the ecology of the microbiota in
our whole body.
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Gut microorganisms have been known for decades to be involved in
the biotransformation of xenobiotics. Approximately 1500 biocatalytic
reactions on environmental pollutants have been listed. In a recent re-
view analyzing various studies using isolated bacteria, or fecal/caecal
suspensions from humans or animals, it was noted that human or rat
feces could detoxify PAHs (polycyclic aromatic hydrocarbons), nitro-
and nitrated PAHs, some pesticides, PCBs (polychlorobyphenyls), and
azo-dyes (Claus et al., 2016). These compounds are known to have car-
cinogenic, and/or mutagenic properties, and exposure to some of them
(like PCBs) has also been associated with impairment of the immune
system, metabolic disruption, delayed neurodevelopment and adverse
reproductive outcomes. Bioactivation of some toxic compounds (in par-
ticular some benzene derivatives) by intestinal microbiota was also ob-
served. In conclusion, the gut microbiota is potentially a major player in
the toxicity of environmental pollutants (Claus et al., 2016).
2.2.4. Microbial biodiversity
The bulk of research data already suggest that a microbiota with a
high level of biodiversity is generally linked to good health, especially
for preventing NCDs (Cotillard et al., 2013; Ege et al., 2011; Haahtela
et al., 2015; Le Chatelier et al., 2013). This is consistent with the so-
called “biodiversity hypothesis” or “old friends” hypothesis (Rook et
al., 2004; von Hertzen et al., 2011), and (workshop presentations by
Dao, 2016; Furman, 2016; Ruokolainen, 2016). Some of the microbes
met by man in early times evolved symbiotically or commensally with
us and are considered as useful rather than pathogenic (Guarner et al.,
2006; Rook, 2013; von Hertzen et al., 2011). By contrast, considerable
environmental disturbance, such as the Neolithic agricultural revolu-
tion, may have favored the emergence of microbial strains that are
more likely to predispose to or cause disease. It has been demonstrated
that the fecal microbiota of children living as humans at the birth of ag-
riculture is signiﬁcantly different from the microbiota of European chil-
dren with modern food and lifestyle (De Filippo et al., 2010). Still more
signiﬁcant perturbations of the relationship between humans and na-
ture happened in the last centuries with urbanization, development of
very large communities, intensive agricultural systems, excavating in-
dustries and other landscape disturbing works like large dams, and
fast travel. This drives microbial evolution favorable for the appearance
of pathogenic strains (Workshop Session, 2016c) and has also consider-
ably changed the exposure of human beings to “ancient” microbiota
(Daszak et al., 2001; Harper and Armelagos, 2010; Karesh et al., 2012).
Whether the reduced microbial exposures linked to modern life condi-
tions contribute to increased susceptibility to inﬂammatory diseases is a
hypothesis that is currently being explored, and is discussed further
below.
3. The compositionof the humanmicrobiota, and impacts onhealth:
genetics vs lifestyle and lifecycle
While data exist on other human microbiota, in particular those of
the skin and respiratory tract, most studies have concentrated on the
gut. The adult human gut microbiota is dominated by the phyla
Firmicutes and Bacteroidetes (~90% of total population), followed by
members of the Proteobacteria and Actinobacteria, which are much less
abundant (b1–5%). The phylum Bacteroidetes contains the well-known
genera Bacteroides and Prevotella. Firmicutes constitute the largest bac-
terial phylum,which contains N200 genera, including clostridial clusters
and Ruminococcus. Proteobacteria are facultative anaerobic bacteria that
include the well-known Enterobacteriaceae family and may represent
only ∼0.1% of the total population. The phylum Actinobacteria includes
the genus Biﬁdobacterium and their abundance varies greatly (from 90
to 2%) depending on age and diet (Gerritsen et al., 2011). In some pop-
ulations Actinobacteria are increased in obese individuals (Castro-
Penalonga et al., 2017). In an attempt to classify human subjects accord-
ing to their microbiota, the concept of enterotypes was developedconsisting of three different groups according to the dominant genera:
Bacteroides, Prevotella, and Ruminococcus, though it is not clear whether
it is more realistic to think in terms of discrete enterotypes or of contin-
uous spectra of microbial composition (Cani and Everard, 2016; Knights
et al., 2014).
3.1. Genetics and the human microbiota composition
The relative contributions of genetics, environment, and lifestyle fac-
tors, to the composition of our gut microbiota is far from fully under-
stood (Spor et al., 2011). Although diet has an obvious effect (Blanton
et al., 2016; David et al., 2014; De Filippo et al., 2010; Ridaura et al.,
2013), host genetics and interpersonal variation also have a profound
impact (Dabrowska and Witkiewicz, 2016; Goodrich et al., 2016;
Goodrich et al., 2014; Lahti et al., 2014; Olivares et al., 2015; Org et al.,
2015). Thus genetics, diet, environment and the microbiota interact.
The individual's gut microbiota is partly determined by genetics and
seems to inﬂuence the effectiveness of dietary intervention to lose
weight (Nadal et al., 2009).Work is in progress to unravel the respective
roles of genetics, birth mode and early feeding in the development of
gut/immune system/microbiota relationships.
3.2. Diet and the composition of human microbiota
Many studies have shown that dietary habits modulate the compo-
sition of the gutmicrobiota but effects vary depending on the type of di-
etary change, and whether long- or short-term dietary patterns are
considered (Benítez-Páez et al., 2016; Portune et al., 2016). For example,
the relative ratio between these so-called “enterotypes” has been
shown to be broadly affected by long-term dietary habits but not by
short-term intervention (Wu et al., 2011). However, there aremany ex-
amples showing that different dietary habits and patterns (e.g. vegeta-
ble rich diets, in particular containing ﬁber, vs. diets rich in animal
products, mainly meat) as well as short-term dietary interventions,
lead to signiﬁcant compositional and functional differences in the gut
microbiota (Falony et al., 2016; presentation by Raes, 2016). The differ-
ent bacterial populations colonizing the human gut are not susceptible
to changes in the diet to the same degree. Depending on the age of
the host and the nature of its initial microbiota composition, some
groups of bacteria seem to remain unaffected by dietary change (pre-
sumably those that can use a wide array of nutritional resources and
are ﬂexible enough to adapt and thrive irrespective of host dietary con-
stituents). Consumption of ultraprocessed foods (e.g. preserved meats,
reﬁned grains, hydrogenated oils) encouraged by the media and adver-
tising, is linked with dietary patterns, particularly the Western-style
diet, that are associated with lower microbial diversity and increased
chronic disease risks (Broussard andDevkota, 2016;Mozaffarian, 2016).
3.3. Microbiota and antibiotics
In addition to food, any absorbed substances, including pharmaceu-
tical products such as metformin used to treat type 2 diabetes, have an
obvious impact on gut microbiota (Forslund et al., 2015). Studies on
human cohorts show the inﬂuence of treatments with laxatives, hor-
mones and immunosuppressive compounds on the composition of the
gut microbiota (Falony et al., 2016), and above all a major inﬂuence of
antibiotics (Jernberg et al., 2010; Korpela et al., 2016).
Antibiotics not only reach pathogenic bacteria but also impact our
beneﬁcial microbiota, leading to perturbation of its composition and
biodiversity, and often to an increase in Proteobacteria because of the
high content of antimicrobial resistance genes in this phylum. The dis-
ruption of our microbiota caused by antibiotics favors the development
of NCDs characteristic of dysbiosis (Francino, 2015; Gensollen et al.,
2016). The risk of obesity, atopic disease, asthma, Crohn's disease, type
2 diabetes, auto-immune diseases (like type 1 diabetes) have been
shown, in human epidemiological studies, to be positively correlated
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inGensollen et al., 2016; Trasande et al., 2013). Themicrobiota of infants
whowere not treated by antibiotics but whosemothers received antibi-
otics before delivery showed the same alterations as infants treated by
antibiotics, with consequences in later life (Tanaka et al., 2009). An im-
portant aspect of this problem is the fact that doctors are often forced by
anxious parents to provide antibiotics for which there is no justiﬁcation.
This situation is exacerbated in countries where antibiotics are available
to the public without a prescription. This misuse is harmful to the chil-
dren, and antibiotic resistance is reaching a crisis point (Van Puyvelde
et al., 2017).
The organisms depleted by antibiotics include microbes that protect
us against infectious pathogens or parasites. As a consequence of the
substantial loss of gutmicrobiota biodiversity caused by antibiotics, sus-
ceptibility to opportunistic pathogenic infections can increase. This is
conﬁrmed in antibiotic-associated diarrheas due to nosocomial patho-
gens, like Staphylococcus aureus and Clostridium difﬁcile inducing poten-
tially lethal colitis. Risk of sepsis has also been related in premature
infants to the length of treatment with broad spectrum antibiotics and
the consequent altered gut microbiota (Madan et al., 2012).
This reveals another aspect of the harmful effect of antibiotics. Those
defensive microbes that are eliminated by antibiotics could be consid-
ered as useful alternatives to antibiotics (see section below: Microbiota
and current medical intervention) in a period of disease emergence or
re-emergence (see session on zoonotic diseases of the workshop) and
when resistance to the classical antibiotics is increasing.
Those defensivemicrobes act throughmechanisms that it will be im-
portant to understand if we want to exploit them to modulate our mi-
crobiota and use them as alternatives to antibiotics. They can act
through direct interaction with the pathogen/parasite (by production
of compounds that are toxic to the pathogen, or killing or parasitising
the pathogen, or by competing for host resources) or through host-me-
diated effects (eliciting an efﬁcient immune response of the host to-
wards the pathogen, or enhancing the host tolerance towards the
pathogen) (Ford et al., 2016; Ford and King, 2016). Those different
mechanisms of action imply different patterns of adaptation and co-
evolution between host, defensive microbe and pathogen.
Antibiotics also have the disadvantage that they enrich our gut mi-
crobiota in antibiotic resistance genes (ARGs). The gut has been
shown to be a very favorable site for horizontal gene transfer, including
between different bacterial species (Liu et al., 2012; Smillie et al., 2011).
This transfermay include ARGs and has been shown to be stimulated by
low concentrations of antibiotics (Whittle et al., 2002). Infants may in-
herit ARGs from their mother even before birth (Francino, 2015). The
abundance of ARGs in our intestine is directly correlated with the time
that the relevant antibiotics have been on the market and approved
for human and animal use (Francino, 2015).
Spread of the antibiotic resistance genes often used to select trans-
genic plants is of particular concern, and has been documented
(Turrini et al., 2015). These genes could be transferred from GM plants
to bacteria in the rhizosphere or in the intestine. Both environments
are hot spots for horizontal gene transfer (Liu et al., 2012; Smillie et
al., 2011; Turrini et al., 2015).WHOhas drawn attention to this problem
(WHO, 1993), and asked for transition towards other existing marker
technologies (reviewed in Breyer et al., 2014; Turrini et al., 2015), and
emphasized this subsequently in a joint report with the Food and Agri-
culture Organization (FAO/WHO, 2000). After repeated discussions and
some internal disagreements, the European Food Safety Authority rec-
ommended that only genes coding for resistance against antibiotics
supposedly not used any more in human and veterinary medicine in
the European Union should be allowed when making GM seeds and
plants in the EU (European Food Safety Authority, 2009). The European
Commission ﬁnally stated that “the applicant shall aim to develop GMOs
without the use of antibiotic resistance marker genes” since “it is now pos-
sible to develop GMOs without the use of antibiotic resistance marker
genes” (European Commission, 2013). Horizontal gene transfers, inparticular between different phyla, are often considered as rare events,
but few if any studies have analyzed the potential cumulative impacts of
such events, and a recent report has drawn attention to the potential
importance of the spread of such resistance genes in the environment
(Midtvedt, 2014).
Currently the ecological functions and services that are involved in
the regulation of resistance to antibiotics are poorly understood
((Workshop Session, 2016a), and see further sections of this review:
“Microbiota, adaptation and evolution: examples in animal species”,
and “Inﬂuence of chemical substances on the microbiota: still a lot to
explore”).
In addition to protecting us against pathogenic microorganisms, our
gut microbiota can metabolize environmental chemical pollutants, as
outlined above. By disrupting the equilibriumof bacteria in our guts, an-
tibiotics may alter the ability of our microbiota to metabolize environ-
mental chemicals.
3.4. Contact with the natural environment and its effects on the microbiota
Residential proximity to the natural environment has striking effects
on overall health (Maas et al., 2006; Mitchell and Popham, 2008). In the
past, it was assumed that these beneﬁts were attributable mostly to re-
laxation, exposure to sun, and exercise, but while these factors do un-
doubtedly enhance health, it is now clear that exposure to microbial
biodiversity from the natural environment is also important (reviewed
in Rook, 2013).
Living in proximity to the natural environment affects the composi-
tion of the skinmicrobiota (Hanski et al., 2012; Ruokolainen et al., 2017;
Ruokolainen et al., 2015), and increases exposure to microbial biodiver-
sity via the airways (Moore, 2015; Rook, 2013; Schuijs et al., 2015). Un-
fortunately, no complete and conclusive studies yet compare the gut
microbiota of people living close and far away from green areas in big
cities but work is in progress (Mhuireach et al., 2016). However, studies
in several countries show a large difference in gut microbiota composi-
tion between people living in urban and in rural areas (workshop pre-
sentation by Raes, 2016; Winglee et al., 2017). Interestingly, physical
exercise, which is more prevalent in green environments, has been
added to the list of factors reported to modify the gut microbiota
(Cook et al., 2016). Moreover, characterizing the human fecal microbi-
ota of long-gone people on archeological sites revealed microbial com-
munities similar to those of present–day residents of remote rural
areas (Tito et al., 2012).
Themicrobiota of buildings containing plants is richer in diversity of
microbes than that of buildings deprived of plants (Mahnert et al.,
2015). The impact on our internal microbiota and health however re-
mains to be studied (Berg et al., 2014b, c). The microbiota of a building
is also inﬂuenced by the construction materials used and can inﬂuence
our internal microbiota and thus health (many studies in USA; very
few in the EU) (Hoisington et al., 2015; Levin et al., 2015; NESCent
Working Group on the Evolutionary Biology of the Built Environment
et al., 2015).Moreover, modern biocide-treated buildingmaterials, con-
crete and plastic, when damp and degrading, can become colonized
with unusual strains of bacteria and fungi producing secondary metab-
olites that are toxic to humans. Traditional buildings that used untreated
timber, dung, mud and thatch contained strains from the natural envi-
ronment similar to those with which humans co-evolved (Sahlberg et
al., 2010).
3.5. Epigenetic effects of the microbiota
Interestingly, diet, but also other factors, affect more than just the
health of the individual concerned. Recent evidence suggests that diet
may also inﬂuence the health of the progeny. A well substantiated
transgenerational hypothesis is emerging. Epigenetic effects of the mi-
crobiota on the host genome have been described, and might explain
some transgenerational inheritance of the impacts of the microbiota
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2016). There seems to be a critical window during early mammalian de-
velopment, including the in utero period, during which environmental
factors can cause epigenetic modulation of the genome. The relevant
factors include the maternal diet and antibiotic use (Cox et al., 2014;
Heard and Martienssen, 2014; Rando and Simmons, 2015; Supic et al.,
2013; Vickers, 2014), possibly acting through the intermediary of the
microbiota (Kumar et al., 2014; Paul et al., 2015). This can have long-
lasting consequences on health, or predispose to NCDs. Thus the data
suggest thatwesternized dietary habits of themother during pregnancy
shape disease susceptibility proﬁles of her descendants via epigenetic
mechanisms (de Assis et al., 2012).
Recent studies on an animal model provide direct evidence that the
gut microbiota is indeed a key mediator of diet-induced
transgenerational disease predisposition (workshop presentation by
Poutahidis, 2016). In mice, diet-induced maternal gut dysbiosis not
only transcends the local boundaries of GI tract, but may undermine
the health of the progeny as well (Poutahidis et al., 2015). In that
study, mice with a Western-type diet and obesity-related gut microbi-
ota had descendants over two generations which, although fed normal
diets, developed lung and liver cancers, and lymphomas at particularly
high rates, coexisting with an increased systemic inﬂammatory tone.
But these adverse health effects in descendantmice, including high can-
cer incidence, were prevented by daily consumption of the probiotic
bacterium Lactobacillus reuteri (Poutahidis et al., 2015).
3.6. The microbiota in early life
Against this background of genetic and epigenetic determinants, the
human microbiota seems to be rather ﬂexible during the early life pe-
riod. Until the age of three years it remains sensitive to various inﬂu-
ences that can impact its composition and cause long-term effects on
our physiology (Clemente et al., 2012; Dogra et al., 2015; Koenig et al.,
2011; Rautava et al., 2012).
Retrospective epidemiological studies in humans indicate that the
microbiota acquired during the perinatal period and early infancy has
important effects on the developing immune systemand on its systemic
role in health or disease later in life (Gensollen et al., 2016). Similarly,
the early airway microbiota may prime the developing pulmonary im-
mune system, and dysbiosis in its development may set the stage for
subsequent lungdiseases (Lal et al., 2016). Notably, there are less allergy
symptoms in children who grow up in natural environments with rich
microbial diversity than in children in urban areas deprived of microbes
withwhichhumans evolved (vonMutius andVercelli, 2010). The ability
of exposure to the natural environment to reduce the risk of allergy dur-
ing childhood has been corroborated in piglets (Lewis et al., 2012). Such
a long term effect on the immune system is particularly important given
that this system is a major communication link between the external
environment and internal mammalian body, including the brain (Rook
et al., 2014b). In the holistic integrative approach of OneHealth/
EcoHealth which considers human and animal health within the
broader context of their environment, one way of communication be-
tween the internal body and the external environment is via environ-
mental microbial signaling to the immune system.
Similarly, natural childbirth (vaginal delivery) (Jakobsson et al.,
2014; Kristensen and Henriksen, 2016) and breast feeding (Latuga et
al., 2014), help to transmit microbes (or factors stimulating the growth
of some bacterial strains) from mother to child (Charbonneau et al.,
2016; Mueller et al., 2015). All this is consistent with the fact that
germ-free animals are sensitive to the various pathologies mentioned
above that are mediated by immune system dysfunction. Animal data
show that the maternal microbiota has effects on the development of
the fetal immune system, perhaps even in utero (Hornef and Penders,
2017; Romano-Keeler and Weitkamp, 2015). The development of the
infant small intestine is also dependent on bacterial colonization that
contributes greatly to its future normal function (Yu et al., 2016).3.7. The microbiota in later life
Later in life, however, during the transition to adolescence and adult-
hood, the link betweenmicrobes dominating themicrobiota in early in-
fancy and health status is still less clear but knowledge is progressing
(Falony et al., 2016).
To explain some apparent inconsistent data on the impacts in later
life of the microbiota met in early infancy, some authors suggest that
‘old friends’ microbes have a crucial effect on the initial development
of our immune system in early infancy or even before birth, and that
the impact of these effects lasts throughout life. But the training of the
immune system may need to be regularly renewed in later life by new
exposures to “good” microbes (Rook et al., 2014a). Lack of this regular
training may lead to impaired immune tolerance and dysregulation of
the immune system that play an essential role in the genesis of non-
communicable diseases (Rook et al., 2014a). Even diseases of the central
nervous system like Alzheimer's might be linked to a “lack of training”
of the immune system by disconnection from the natural environment,
including its microbes (Fox et al., 2013).
The gut microbiota in human adults is more resilient than in early
life and seems largely deﬁned by its progressive acquisition and stabili-
zation through long term dietary habits and our general living environ-
ment (Falony et al., 2016; workshop presentation by Raes, 2016; Wu et
al., 2016).
Recent data indicate that even in adult animals gutmicrobial compo-
sition mediates epigenetic programming in multiple host tissues in a
diet-dependent manner. In a mouse model, a Western-type diet pre-
vents many microbiota-dependent chromatin changes that occur on a
polysaccharide-rich diet. Concomitantly, a Western-type diet limits mi-
crobial SCFA production. Supplementation of germ-free micewith SCFA
(known to play an important role in immunity) recapitulates chroma-
tin-modiﬁcation states associated with bacterial colonization
(Krautkramer et al., 2016). These observations may help to explain the
inﬂuence of diet in later life on microbial impacts acquired in early
life. For example, in another mouse model, the composition of the gut
microbiota was shown to be impacted mainly by early life history and
genetics and less inﬂuenced by dietary changes,whereas the gutmetab-
olomewasmostly shaped by diet with speciﬁc non-dietary metabolites
of microbial origin (Snijders et al., 2016). Loss of biodiversity in the gut
microbiota in the elderly is associated with systemic markers of inﬂam-
mation, and declining health (Claesson et al., 2012). Thus diet and our
general environment and lifestyle can inﬂuence our microbiota and
health throughout life, as discussed further in other sections.
4. Use of microbiota in clinical intervention
In recent years, microbiota research has attracted a lot of attention
worldwide since it holds promise for counteracting pathologies that
are an alarming burden in modern industrialized societies and that are
also increasing rapidly in developing countries as they adopt western
diets and urban lifestyles. More research, and especially clinical trials
are needed to ensure the safety and efﬁcacy of novel applications such
as food products targeting the gut microbiota as disease prevention or
therapy. As a pioneer in curative use of microbes, the technique of
fecal microbiota transplantation (FMT) has emerged to counteract
health problems due to intestinal dysbiosis (workshop presentation
by Stephenne, 2016). This method attempts to replace harmful bacteria
in the intestine of a patient with a more balanced “healthy” microbiota.
The latter comes from a healthy donorwithout drug treatment and hav-
ing a family history free of chronic disease, especially gut-microbiota as-
sociated. In Belgium, fecal transplantation is at present considered as a
tissue transplantation following the advice of the national Superior
Council of Health. The method has been used in many different coun-
tries and brings good results against diarrhea caused by overgrowth of
multi-resistant Clostridium difﬁcile usually resulting from multiple anti-
biotic treatment, that causes disturbed gut microbiota (Kachrimanidou
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tablish guidelines of technical, regulatory, administrative and laboratory
requirements for the implementation of fecal transplants for C. difﬁcile
infection (Cammarota et al., 2017). Convincing data for other therapeu-
tic applications are currently lacking. Attempts to treat ulcerative colitis
have only shown a beneﬁcial effect in speciﬁc populations (yet to be de-
termined). This technique provokes few side effects, and holds promise.
But sound data from clinical trials are needed before considering the
treatment of more intestinal diseases linked to dysbiosis, and perhaps
even for treatment of psychological pathologies (Dinan and Cryan,
2013). It must be noted that the colonic microbiota, currently used in
these transplantations, is not representative of the microbiota in all
parts of the intestine. The precise results of the technique seem to be in-
ﬂuenced by the biodiversity of the donormicrobiota. More standardiza-
tion is obviously needed to make this technique operational and safe.
Cryo-preservation banks of fecal material should be constituted to im-
prove the research in this ﬁeld. Such banks would enable epidemiolog-
ical studies and enhance both safety and efﬁcacy. The characteristics of
the microbiota in each sample could be linked to clinical results in the
recipient. The strategy would also be improved if we could develop
our capacity to grow the consortia of beneﬁcial bacteria in laboratory
conditions to ensure safety and reproducibility. A careful but not too
complex regulation will be necessary to reduce the risks of “auto-med-
ication” (Vandenplas et al., 2015).5. Biodiversity and the plant and soil microbiota
Regarding the importance of microbial diversity, it is useful to draw
parallels with knowledge gained from other microbial systems, includ-
ing the plantmicrobiota and its interactionwith the soilmicrobiota (Fig.
2) (workshop presentation by Berg, 2016). We also need to explore
their links with human microbiota and health.Fig. 2. Animals and plants have similar associations with microbiota. Plants have microbiota
organisms associated with the roots (rhizosphere) are attracted and nourished by molecules s
This situation clearly parallels the organisms associated with the mucus layer in the colon, wh
signals (e.g. short chain fatty acids) to the host.5.1. Biodiversity of the plant microbiota
In parallel to what is found in animals, the microbiota of plants de-
pends on species, genotype and the environment, differs in various or-
gans and tissues such as leaves, roots and fruits, and changes with age
(Wagner et al., 2016). Interestingly, microbes present inside or on the
surface of the seed have a key role in the development of plantmicrobi-
ota (Barret et al., 2015), which is reminiscent of the role of perinatal mi-
crobiota exposures in animals.5.1.1. Plant microbiota and plant health
The plant microbiota has been known to be one of the key determi-
nants of plant health and productivity for more than a century
(Hartmann et al., 2007). Brieﬂy, its impact can be summarized as ﬁve
key roles: (i) improving nutrient acquisition and growth, (ii) sustaining
plant growth under biotic and/or abiotic stress, (iii) inducing resistance
against pathogens, (iv) interacting with plant or human pathogens, and
(v) interacting with other trophic levels like insects (Massart et al.,
2015). Both gut and root bacteria contribute to host metabolism, pro-
duce similar bioactive compounds, such as vitamin B12, and compete
with pathogens for successful colonization (Bakker et al., 2014). They
both affect host gene expression and also adjust their own gene expres-
sion proﬁles according to the host's physiological and circadian rhythm
(Leone et al., 2015; Thaiss et al., 2014). Dominant as well as minority
bacterial population species in both mammalian gastrointestinal tracts
and plant roots have been shown to have important symbiotic roles
(Ramirez-Puebla et al., 2013). Interestingly, the microbiota of the
plant root interacts with its soil microenvironment (rhizosphere) mi-
croorganisms to achieve symbiotic beneﬁts (Berg and Smalla, 2009;
Peiffer et al., 2013; Schlatter et al., 2014; Smalla et al., 2001). Towhat ex-
tent this phenomenon translates to the mammalian host-environmen-
tal interaction warrants further investigation (Fig. 2).both within their tissues (endophytes) and on their surfaces (epiphytes). Some of the
ecreted from the roots, and then take part in 2-way signaling and exchange of nutrients.
ere the mucus nourishes the microbiota, which in turn provides nutrients and metabolic
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plant microbiota may stimulate studies on animal microbiota and vice
versa (Berg et al., 2015b; Mendes and Raaijmakers, 2015; Ramirez-
Puebla et al., 2013).
5.1.2. Plant microbiota and human health
Moreover, it has been suggested that humans gain health beneﬁts
from internalizing plant microbiota either through food or through
breathing (Berg et al., 2015a, 2014a, c; Moore, 2015), though this area
is currently severely under-investigated.
5.2. Biodiversity of the soil microbiota
Soils harbor very abundant and dynamic microbiotas that are inﬂu-
enced by the physico-chemical properties of the soil, the climate, other
trophic levels (plants, macrofauna), depositions (through air dust or
water) and human management.
It has been suggested that plant diversity contributes to plant com-
munity resistance against pathogens by fostering beneﬁcial bacterial
communities in soils (Latz et al., 2012). This indirect soil feedbackmech-
anism may contribute to the positive relationship between plant diver-
sity and productivity. Microbial biodiversity ensures an equilibrium
between various strains and their balanced complementary functions
(workshop presentation by Berg, 2016; Berg et al., 2013). In this con-
text, the excess proliferation of opportunistic pathogens might be
prevented (Latz et al., 2016). Disease in plants is often associated with
an unbalanced composition of themicrobiota colonizing not only its or-
gans and tissues but its soil environment aswell (Berg et al., 2015b; Latz
et al., 2016). This parallels the connections of animal and human disease
with host and environmental microbiotas. Along these lines, biocontrol
practices using bacterial inoculants to promote plant growth and health
are equivalent to the use of probiotics for animal or human health. Bio-
control of plants through plant-probiotics, which is neither standard-
ized nor easy to achieve, is currently under intense investigation (van
der Heijden et al., 2016). Similarly, there are novel approaches based
onmolecules able to improve the direct or indirect effects of microbiota
against plant pathogens. Some of these molecules could be considered
as plant prebiotics (Massart et al., 2015).
5.2.1. Soil microbiota and human health; mycobacteria
It has been suggested that soil biodiversity is important for human
health (Wall et al., 2015). As was pointed out in the section on the
mechanisms of health beneﬁts from microbiota, one crucial role is pro-
viding antigenic diversity that expands the repertoire ofmemory T lym-
phocytes. The mycobacteria are of particular interest in this context.
Most studies of the microbiota fail entirely to report mycobacteria, de-
spite the fact that all soil and many water supplies are enormously
rich in members of this genus (Pontiroli et al., 2013). Moreover, we
have known for decades that in rural environments most individuals
show skin-test reactivity to reagents prepared frommycobacteria living
in their geographical area (Fine et al., 2001). Thus, immunologically rel-
evant exposure deﬁnitely occurs. This is not surprising, since it has also
been known for decades that whenmycobacteria are ingested they rap-
idly associatewith gut epithelial cells, and translocate to Peyer's patches
(Sangari et al., 1999). Recently, the failure of “omics” approaches to re-
port themycobacteria has been demonstrated by a study that used dras-
tic methods to break down the tough mycobacterial cell wall. This
approach revealed the presence of mycobacteria in the oropharynx of
all donors investigated (Macovei et al., 2015). Therefore, mycobacteria
will provide a substantial data input to the dendritic cells in the small
bowel that sample gut contents (Schulz and Pabst, 2013). The
mycobacteria paradigm is important in that regard. It is now clear that
vaccinationwith Bacillus Calmette Guerin (BCG; amycobacterium)pro-
vides health beneﬁts that go far beyond some protection against tuber-
culosis (Kleinnijenhuis et al., 2015; Netea and van Crevel, 2014). BCG
vaccination causes an increase in survival that is independent oftuberculosis. It is therefore possible that BCG vaccination is in some
way compensating for mycobacterial exposures that would have been
inevitable in human populations living close to the soil.
Interestingly, the mycobacteria paradigmmay overlap with the edi-
ble plant endophytes hypothesis. Indeed, mycobacteria can be internal-
ized by plants, and up to 104/gM. avium organisms were demonstrated
inside plant tissues (Kaevska et al., 2014). Thismycobacterial species is a
well-known pathogen of animals and immunocompromised humans
(Sangari et al., 1999). The importance of human immune system expo-
sure to low doses of bacteria contained in edible plants, where adapta-
tion to the plant environment might reduce virulence for humans,
should be further investigated (workshop poster by Massart et al.,
2016).
5.2.2. Soil microbiota and human health; spores
The modern built environment and air-conditioned buildings must
also reduce our exposure to bacterial spores, and this issue is often
neglected. Spores are remarkably resistant, and can remain viable for
thousands, possibly millions of years (Nicholson, 2002). They are rele-
vant in two contexts. First, about 1/3 of the organisms in the gut micro-
biota are spore-forming, and spores are readily demonstrable in human
feces (Hong et al., 2009a). Human feces contain up to 104 spores/gwhile
soil contains approximately 106 spores/g (Hong et al., 2009b). Wher-
ever humans have lived, the natural environment is inevitably seeded
with the spores of human gut-adapted bacterial strains. A recent study
revealed that the spore-forming strains within the human microbiota
are more diverse than non-spore-forming bacteria and show a higher
species turnover or a greater shift in relative abundance over the course
of a year (Browne et al., 2016). Therefore, it is possible that when a gut
organism becomes extinct as a result of dietary inadequacy or antibiotic
misuse (Sonnenburg et al., 2016), it can be “reinstalled” via spores from
the environment.
Other spore-forming organisms from the environmentmight also be
important despite not being deﬁnite components of the human micro-
biota. Spores in soil have tended to be studied by environmental micro-
biologists and ecologists, and the soil has been regarded as the natural
habitat of the spore-forming organisms such as Bacillus spp., despite
awareness of the fact that many of them can germinate and replicate
in the intestinal tracts of insects and other animals (Nicholson, 2002).
Bacillus subtilis strains were obtained from biopsies of human ileum
and from fecal samples (Hong et al., 2009a). This organism is an impor-
tant stimulus for development of the gut-associated lymphoid tissue
(GALT) in rabbits and sporulation of live bacilli within the GALT was
considered critical to this process (Rhee et al., 2004). At the very least,
after germinating in the small bowel these organisms will provide
data to the immune system in the ileum where dendritic cells sample
gut contents, and where recently ingested organisms can constitute a
signiﬁcant proportion of themicrobes present (Schulz and Pabst, 2013).
Interestingly, although Gram-negative organisms cannot produce
spores, many of them have similar survival strategies (potent produc-
tion of osmolytes, dormancy, phase variation etc.) that facilitate their
persistence in the environment (Cernava et al., 2016). Thus it is possible,
though not yet proven, that the environment, in addition to providing
“reinstallation” of lost spore-forming organisms, can also act as a source
of relevant Gram-negative components of the human microbiota.
5.3. Microbiota in agricultural systems and food production
Vegetables grown using agro-ecological approaches such as organic
agriculture, carry a much larger microbial biodiversity (endophytes and
epiphytes) than vegetables grown using current conventional agricul-
ture (Fliessbach et al., 2007; Schmid et al., 2011).Whereas some experts
fear this can also be a source of rotting and plant disease, others argue
that a balanced naturalmicrobial biodiversity prevents the proliferation
of strains causing deleterious effects. Pathogen epidemics are indeed
less frequent in wild areas with rich plant biodiversity and a richer
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terms of microbial biodiversity and useful microbe content, is an attrac-
tive “functional food” (Selhub et al., 2014). The hybridized strains of
vegetables and crops tested so far, including lettuce, are drastically re-
duced in microbial biodiversity compared to their parent lines
(Cardinale et al., 2015; Peiffer et al., 2013). This is probably not the result
of the hybridization process itself. Rather it is the breeding and selection
process that has a detrimental effect on the microbiota. The domestica-
tion of plants and animals (and humans) includes the domestication of
the associated microbiota (Cardinale et al., 2015; Pérez-Jaramillo et al.,
2016). One example of this man-made co-evolution is the fate of gluco-
sinolates in Brassicaceae, which, due to their bitter taste, were drasti-
cally reduced by breeding. These compounds protect plants against
pathogens (e.g. Verticillium in oilseed rape) and their metabolites have
anti-cancer activities in humans (Ambrosone et al., 2004; Novio et al.,
2016). The low glucosinolate content in modern Brassica cultivars has
enhanced their susceptibility to plant pathogens, and we need to inves-
tigate whether this loss of glucosinolate has caused the depletion from
human gut microbiota of bacteria with glucosinolate-degrading
capacity.
Recent studies showed thatmoss spores and plant seeds also contain
a core set of plant genotype-speciﬁc, beneﬁcial endophytes, which are
vertically transmitted from one generation to the other (Adam et al.,
2016). These seed microbes were shown to have an impact on plant
health and were strongly driven by domestication and breeding
(Adam et al., 2016). Moreover, some plant phyla cannot germinate
without their indigenous microbes, e.g. mosses or orchids. These novel
insights suggest that seed endophytes can serve as sources for new tar-
gets for agricultural biologicals to translate the “back to the roots” con-
cept that comprises the exploration of the microbiome of wild relatives
of crop plant species for the identiﬁcation of beneﬁcialmicrobes that got
lost during the domestication process and to unravel plant traits in-
volved in microbiome assembly (Pérez-Jaramillo et al., 2016). Thus
missing beneﬁcial microbes can be reinstated from wild relatives.
The link between microbial biodiversity and food also has implica-
tions for food preservation strategies (Coelho et al., 2014; Melero et
al., 2013). Certain microbes naturally protect food such as vegetables
against rotting. However, during food storage, the microbiota proﬁle
changes (Cauchie et al., 2017; Kergourlay et al., 2015), and this capacity
of preservation disappears. Adding “counter-rotting” bacterial strains to
food could reduce a huge amount of food spoilage in the world, cur-
rently 25% of food production (workshop presentation by Taminiau,
2016). Trials are promising, but the impact on the host microbiota is
not known and should therefore be assessed. Moreover, longitudinal
impacts on the food industry of these bioprotection systems are not
known. It may be advantageous to work with cocktails of strains, prob-
ably more potent in preventing food spoilage than individual bacterial
strains. Unlike laws and rules regulating health claims and drug devel-
opment, the legislation for using natural preservative additives makes
it easier to use beneﬁcial bacterial cocktails for the prevention of food
spoilage.
There is a popular notion that eating seasonal food is good for health.
Could this popular concept have a microbiota-related scientiﬁc basis?
For millennia, seasonal change inmicrobiota composition was naturally
linked to seasonal variation of food availability. It possibly matched sea-
sonal physiological status and helped to adapt the host body to various
exterior stresses throughout the year (Ebling, 2015; Follett, 2015;
Maurice et al., 2015; Sommer et al., 2016). This should be viewed in con-
junctionwith recent evidence of annual ﬂuctuations in immune system
function in humans (amore pro-inﬂammatory status during thewinter
period) (Dopico et al., 2015). Moreover, the effect on human health of
the speciﬁc composition of the microbiota of edible plants (epiphytes
and endophytes), and its possible modiﬁcation by different agro-food
systems clearly deserves to be studiedmore carefully (workshop poster
by Massart et al., 2016).Also, it will be important to investigate how different agricultural
systems impact environmental microbiotas and thereby the health of
farming and other rural communities. A recent study compared farmers
from the same country, with similar genetics, diets and lifestyles, but
with very different farming systems. Asthma was ~4 times more fre-
quent in children of farmers practicing highly industrialized agriculture
than in children of those practicing traditional family farming with
horses as labor force (Stein et al., 2016). The lower risk of asthma
could be correlated with higher endotoxin levels in the Amish house
dust, which was also effective in blocking allergic responses in a
mouse model. This suggests that the different agricultural practices re-
sulted in different microbial composition of the aerosols to which the
populations were exposed.
5.3.1. Effect of transgenic plants on environmental microbiota
Wealso need to considerwhether transgenic crops, and other genet-
ically modiﬁed organisms or GMO cause unacceptable changes to the
microbiota of the host or environment (Azevedo and Araujo, 2003;
Kramkowska et al., 2013; Turrini et al., 2015). The issue of spread of an-
tibiotic resistance genes incorporated into many GMOwas discussed in
Section 3.3 “Microbiota and antibiotics”.
In some cases, the transgene product directly modiﬁes the gut mi-
crobiota of animals that consume it (for example polyphenol-enhanced
apples). In this example the effect is regarded as beneﬁcial to the host,
but this will not always be so (Espley et al., 2014). As far as the environ-
ment is concerned, there is good evidence that products of GM plants
can be exuded from the roots and that some persist in the soil for long
periods. Various effects of GM crops on endophytes or on microbes of
the rhizosphere have been observed (reviewed in Turrini et al., 2015).
These effects can be mediated by the intended products of the
transgenes, or by unexpected production of metabolites resulting from
pleiotropic effects of the transgene technology (reviewed in Turrini et
al., 2015). Results with Bt (Bacillus thurigiensis) insecticide-producing
GMplants suggest that, in this case at least, it is these pleiotropic effects,
rather than the product of the transgene, thatmodify themicrobiota, ar-
guing in favor of the European GMO legislation that assesses the GMOs
by “event”. However existing studies fail to answer crucial questions:
are the effects on the environmental microbiota of a speciﬁc transgenic
crop greater than the differences that would be found between a range
of conventional cultivars under the same tillage and cultivation condi-
tions, and are those effects crucial for soil health? At present it is not
clear that the effects seen are harmful, but close scrutiny is essential.
Special attention should be given to: - 1) foreseeable impacts on envi-
ronmental and/or intestinal microbiota of transgene products that
have antimicrobial or antifungal effects; 2) foreseeable (on the basis of
the transgene function) or unforeseeable (through unexpected pleio-
tropic effects) impacts on microbial communities that play key ecosys-
tem services in the soil, such as decomposition of crops residues,
completion of biogeochemical cycles, maintenance of soil fertility and
plant nutrition.
6. Microbiota, adaptation and evolution: examples in animal species
Contrary to themain cellular genome of eukaryotes, which is largely
static, the microbiome is highly plastic, and can respond rapidly to
changes in host diet or environmental conditions. It may thus represent
an important source ofmetabolic ﬂexibility for the host. As such, the gut
microbiome is sometimes referred as our “third malleable genome”,
(the second being the mitochondrial genome), and is increasingly hy-
pothesized to play a role in host ecology and evolution (Carroll et al.,
2009).While most biologists agree that microorganisms play an impor-
tant role in host evolution, the idea that the host and its associated mi-
croorganisms form a primary unit of natural selection, and represent
two components of a uniﬁed genome, is more controversial
(Rosenberg and Zilber-Rosenberg, 2016). Especially, how gut symbionts
evolve, and whether they undergo natural selection to beneﬁt their
1028 L. Flandroy et al. / Science of the Total Environment 627 (2018) 1018–1038host, is still far from evident. Indeed, the gut microbiota is a complex,
heterogeneous and variable community of microbes, which is assem-
bled anew in each host generation through different transmission
routes. At one extreme, gut symbionts can be directly transferred from
mother to offspring, but most of the time they are randomly picked up
from the environment. This molecular dialog between host immunity
and gut symbionts plays a crucial role and is starting to be
deciphered. These interactions are currently placed in an eco-evolu-
tionary context reﬂecting the role of the microbiome in host
acclimatization and adaptation in fast changing environments
(Macke et al., 2017).
First, the invertebrate zooplankton constituent Daphnia is an inter-
esting model in which to study symbiotic co-evolution and adaptation
of organisms with their microbiota (Callens et al., 2016; Decaestecker
et al., 2013). Experiments in this ecotoxicological model have shown
that the gut microbiota of these small crustaceans confers resistance
against toxins produced in the water by cyanobacteria (workshop pre-
sentation byDecaestecker, 2016).Microbiome-linked resistancewas in-
creased by previous exposure (selection over generations) of Daphnia
(containing microbiota) to cyanobacteria, and this resistance was con-
served across generations and transferred by themicrobiota of resistant
Daphnia genotypes to susceptible genotypes. Conversely, transfer of the
microbiota from susceptible genotypes to germ-free resistant geno-
types makes these resistant genotypes sensitive again to cyanobacteria
toxins. Altogether, this suggests bi-directional interaction of the micro-
biota with the Daphnia which can help in the degradation of the harm-
ful cyanobacterial toxins, threatening freshwater ecosystems.
A second example of microbiota mediating increased resistance to
biotic stress is found in amphibian populations that are threatened
worldwide by the fungal pathogen Batrachochytrium dendrobatidis
(Bd). This biodiversity problem could generate amplifying ecosystem
disturbances. But, the skin microbiota plays a role in amphibian resis-
tance to Bd, and this ﬁnding is intensively studied in the hope that it
can save this category of animals from extinction (Walke and Belden,
2016). Host factors seem to select for environmental microbes coloniz-
ing the skin, which in turn inﬂuence Bd infection or are inﬂuenced by it.
Experiments have demonstrated that an augmented protective micro-
biota can reduce morbidity and mortality in amphibians exposed to
Bd. Bacterial metabolites were shown to inhibit Bd zoospore coloniza-
tion or development. Interestingly, the anti-Bd metabolite tryptophol
was produced when Bacillus sp. and Chitinophaga arvensicola were
grown together, but not when either was grown in isolation, illustrating
the necessary interaction between different microbes to ensure beneﬁ-
cial effects for the host.
The promising protective effect of probiotic isolateswas found to de-
pend on context, including temperature. This animal microbiota model
can also teach us about the protective functions of the human microbi-
ota. Interestingly, just as in humans, the amphibian microbiota was
shown to be shaped by transmission from parents, other individuals,
diet, habitat, other environmental factors and, notably, to change with
the seasons. Lessons from these studies that bring together researchers
from a variety of disciplines (including ecology, microbiology, biochem-
istry, amphibian biology), could also be applied to other organisms af-
fected by pests, from wildlife to agricultural crops, in addition to
humans. Fungal diseases are increasing in incidence and are a major
threat to biodiversity in bees, bats, snakes, corals, and a variety of eco-
nomically important crops (Fisher et al., 2012).
Importantly, it has been observed recently that treating bees with
tetracycline, a broad spectrum antibiotic that is commonly used in com-
mercial beekeeping, results in dysbiosis, increased susceptibility to
pathogens, and increased mortality (Raymann et al., 2017).
7. The ocean; the planet's microbiome gene bank?
We cannot consider the microbiota of soil and terrestrial fauna and
ﬂora without bearing in mind the fact that the oceans are the largestreservoir of microbiota on the planet (Fig. 1). Evidence for direct effects
of ocean microbiota on human health has emerged. Living by the coast
yields health beneﬁts (Wheeler et al., 2012), and ocean spray is a rich
source of microbial biodiversity (Leck and Bigg, 2005; Prather et al.,
2013), and it is possible that this is one reason for the health beneﬁts.
On the rare occasions that marine aerosols contain toxic brevetoxins,
clinical effects can be observed some distance inland, proving that phys-
iologically relevant doses or marine organisms are routinely inhaled
(Kirkpatrick et al., 2008). Moreover, airborne ocean microbiota can
travel a lot further than the coast. Air samples from the upper tropo-
sphere have been shown to contain bacteria frommany sources, includ-
ing the ocean (DeLeon-Rodriguez et al., 2013). The global kinetics of
ocean bacteria and their ability to reach humans directly via the rain
or the air, or indirectly through the food chain warrants further
investigation.
Moreover the ocean microbiota plays key roles in biogeochemical
processes, like carbon and nutrient cycling, essential for the food web
in the ocean ecosystem. The mass of this microbiota feeds the plankton
at the base of the ocean food web. Moreover, photosynthesis in the
ocean provides about half of the oxygen present in the Earth's atmo-
sphere. It is difﬁcult not to make a link with the alarming depletion of
the ocean's oxygen during the last ﬁfty years that could compromise
the ocean's ecosystem services (Breitburg et al., 2018).
In terms of temperature, chemical composition, nutrients, depth
and pressure, the ocean water is a rather variable environment that
favors a large biodiversity of both microbial and eukaryotic marine
life. It thus offers a living laboratory to facilitate comparative analysis
of microbial composition between ecosystems and to study the im-
pacts of environmental changes, and the capacity for adaptation of
microbial communities that play essential roles in the health of our
planet.
Samples from epipelagic and mesopelagic waters across the globe,
have yielded new data on the microbial composition of the ocean
(Sunagawa et al., 2015). A biodiversity rich microbial reference gene
catalogue of ˃40 million non-redundant, mostly novel sequences,
contained in ˃35,000 prokaryotic species, was generated. The ocean
can thus be viewed as a microbial gene bank.
A core of gene families that accomplish stable core functionswas dis-
tinguished from gene families that are involved in variable, adaptive
functions. Curiously, ˃73% of the stable core functionality is shared
with the human gut microbiome, despite the physicochemical differ-
ences between these two ecosystems (mostly anaerobic and hetero-
troph microbes in the gut; mostly aerobic and autotroph microbes in
the ocean). Only the proportion of some functionalities varies (genes
for defense mechanisms, signal transduction, carbohydrate transport
and metabolism more abundant in the gut; genes for transport mecha-
nisms and energy production, more abundant in the ocean). This sug-
gests that most microbes' fundamental functionality has not changed
much during their evolution and that replacement of one microbial
community by another after environmental change can be accom-
plished without excessively difﬁcult adaptation. This is important as
we face climate change. This study revealed that themajor environmen-
tal factor shaping taxonomic and functional microbial communities is
temperature (Sunagawa et al., 2015). Therefore, new communities of
microbes may be able to ﬁll the void left by others as ocean tempera-
tures rise. We might speculate that genes facilitating adaptation to dif-
ferent temperatures could be pinpointed in this gene bank. But the
worry is that these shifts in the microbial community might cause
changes in the nutrients available in the food web of the ocean and
so lead to changes in other fundamental functions accomplished by
the ocean microbiota that impact life and health on earth. For
example, we now know that ocean microbiota and their metabolic
products are present in marine aerosols where they are important
modiﬁers of raindrop nucleation, and therefore of cloud formation
and climate change (Cochran et al., 2017). The health of the ocean
thus deserves to be closely monitored at the level of its microbial
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8. Inﬂuence of chemical substances on the microbiota: still a lot to
explore
Effects of antibiotics and other pharmaceutical products on gut and
environmental microbiota were already mentioned in previous sec-
tions. Here we consider other classes of pollutant derived from
chemicals that are used as pesticides, fertilizers, plasticizers, lubricants,
dispersants, or emulsifying agents, or added to personal care products,
or to food. Recent publications indicate that early-life exposure to envi-
ronmental chemicals and alterations of microbial colonization during
the perinatal period may promote dysregulated immune responses in
later life (Gascon et al., 2013; Maurice et al., 2013; Menard et al.,
2014). Theseﬁndings suggest that the adverse health effects of environ-
mental chemical pollutants, including endocrine disruptors, may not be
restricted to direct toxicity on host cells. Someof themmaybemediated
by effects on our microbiota.
Speciﬁcmembers of numerous chemical classes have been shown to
alter the composition and/or metabolic activity of the internal microbi-
ota in animals (mostly mice) or in SHIME models (Simulator of the
Human Intestinal Microbial Ecosystem). The physiological disturbances
caused were sometimes linked to the altered metabolism of these mol-
ecules by themicrobiota as described in Section 2.2.3, and commonly in-
cluded inﬂammatory disorders, and disturbed energy metabolism
typical of diabetes (reviewed in Claus et al., 2016; Velmurugan et al.,
2017). Endocrine-disrupting properties have been associated with
most of these chemicals, and strong epidemiological studies, supported
by deﬁned biochemical pathways, link the physiological disturbances
they cause to rapid increases in type 2 diabetes in many parts of the
world (reviewed in Velmurugan et al., 2017). For some of these
chemicals, interaction with the AhR (aryl hydrocarbon receptor) was
demonstrated to be a fundamental step in the induction of dysbiosis
and metabolic disturbance (Zhang et al., 2015). We list below some of
the compounds that have been shown to evoke dysbiosis associated
with metabolic alterations (reviewed in Claus et al., 2016; Mnif et al.,
2011; Velmurugan et al., 2017).
- POPS (persistent organic pollutants), in particular a polychlorinated
dibenzofurane (TCDF; tetrachlorodibenzofuran), polychlorinated bi-
phenyls (PCBs), and chlorothalonil (an organochlorine fungicide).
- Organophosphates, less persistent and thus used as 2nd generation
insecticides and herbicides, such as the insecticides diazinon and
chlorpyrifos (Joly et al., 2013), and the herbicide glyphosate (see
below).
- Carbamates and Pyrethroids (3rd generation pesticides, considered
still less toxic), like the fungicide carbendazim and the pyrethroid in-
secticide tau-ﬂuvalinate. The latter caused disturbed bacterial diver-
sity in bees but host metabolism was not studied.
- Bisphenol A (used as plasticizer in various plastic products, including
water bottles and toys). Its toxic effect as endocrine-disruptor has
been recognized ofﬁcially in the European Union, so bisphenol S
has been proposed as an alternative. However, recent tests show
some disturbances in the caecum ofmale animals and the liver of fe-
males (European Chemicals Agency (ECHA), 2014). This sex differ-
ence (also observed for the effects of diazinon, cadmium and lead
(Velmurugan et al., 2017)) might suggest endocrine disrupting
mechanisms, that could operate via the microbiota.
- Phthalates, used in plasticizers, lubricants, dispersants, and personal
care products (e.g. cosmetics, perfumes, nail polishes). In addition to
dysbiosis, exposure of rats to diethyl phthalate led to consistent
weight loss.
- Non-caloric Artiﬁcial Sweeteners (NAS), like aspartame, sucralose,
saccharin
- Emulsiﬁers, like carboxymethyl cellulose and polysorbate-80- Disinfection products like trichloroacetamide
- Heavy metals, in particular tested cadmium, arsenic, and lead (Lu et
al., 2014), contained in synthetic fertilizers.
In addition to the above, combustion of organic materials and accu-
mulation of petrochemical products lead to contamination of the envi-
ronment with polyaromatic hydrocarbons (PAH). Soils experimentally
contaminated with creosote, (a rich source of PAH), contained higher
levels of Proteobacteria and lower levels of Actinobacteria and
Bacteroidetes. Similar alterations in the relative abundance of phyla in
humanmicrobiota have been associated with adverse health outcomes,
including immunological disorders. It is therefore conceivable that neg-
ative health effects of PAHs could bepartly attributable to changes in en-
vironmental microbiota leading secondarily to changes in human
microbiota (Parajuli et al., 2017).
Thus we need to explore how the various agrochemical residues in
food may affect our gut microbiota, either directly, or indirectly via
their inﬂuence on the microbial composition of soil and edible plants
(Claus et al., 2016; Kruger et al., 2013). Impacts of pesticides on the mi-
crobiota of animals have been reported to increase their susceptibility to
infections with high morbidity or mortality and threaten biodiversity
and ecosystem equilibria (Walke and Belden, 2016). Similarly, effects
on pollinators and human food security are important in this context
(Engel et al., 2016).
It is worrying that the list quoted above includes chemicals used in
food and cosmetics, that were previously considered safe for humans.
Sweeteners and emulsiﬁers have been reported to alter the composition
of the microbiota, with potential effects on obesity and other cardio-
metabolic diseases (Chassaing et al., 2016; Roca-Saavedra et al., 2017;
Suez et al., 2014; Suez et al., 2015). Similarly, recent studies highlight
doubts about several substances that are very common in the
human environment. Experiments were performed in rats using
diethyl phthalate (DEP), methylparaben (MPB), or triclosan (TCS),
because DEP is used to stabilize fragrances in perfumes and hygiene
products and increase the ﬂexibility of plastics, while MPB and TCS
are used as preservatives and microbicides. The rats were exposed,
from birth to adulthood, at doses equivalent to human exposure.
There were signiﬁcant changes in overall gut bacterial composition
in adolescent rats, and smaller changes were seen in adults (Hu et
al., 2016). Treatment with mixtures of these compounds resulted
in a distinct microbiome shift different from that caused by the
individual chemicals or attributable to a simple additive effect,
suggesting biological interaction between these chemicals or their
effects.
Some pollutants reach humans via aerosols. For example experi-
ments in mice reveal that ingestion of airborne particulate matter
(urban PM10), already known to impair lung health, also changes
the gutmicrobiome (Kish et al., 2013). This changewas accompanied
by inﬂammatory responses in the intestine linked to enhanced intes-
tinal permeability (Kish et al., 2013). Further study will be required
to prove the cause-effect relationship between the changed microbi-
ota and the inﬂammatory responses, but such a relationship has been
demonstrated elsewhere (reviewed in Erdman and Poutahidis,
2015).
Potential positive or negative effects on our health of cumulative in-
teractions of chemical substances with the microbiota should not be
neglected. For example, it has been reported that the microbiota can
exert an adjuvant effect on cancer chemotherapy (Iida et al., 2013;
Viaud et al., 2013). Other studies have focused more speciﬁcally on
the susceptibility to antibiotics of bacteria when they are exposed to
sublethal doses of commercial formulations of herbicides (Dicamba,
2,4-Dichlorophenoxyacetic Acid, and Glyphosate) (Kurenbach et al.,
2015). Changes in the minimal inhibitory concentrations (MIC) of vari-
ous antibioticswere observed, through direct action of theherbicides on
the phenotype of the bacteria. One mechanism noted was an effect on
the efﬂux pump used by bacteria to move antibiotics from inside the
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ing or decreasing MIC) depended on the herbicide, the antibiotic and
the bacterial species. The effects were observed with herbicide concen-
trations above current food allowedmaximum residues, but within ap-
plication levels for all herbicides, and additive effects were observed
with combinations of some of these products. These effects undermine
antibiotic therapy and drive, in some cases, greater use of antibiotics
for farm animals. This in turn leads to increased exposure of useful in-
sects like honeybees, and favors the selection of genotypes resistant to
these antibiotics. When the MIC is increased, it raises the survival of
populations exposed to ‘normal’ (when tested alone) lethal concentra-
tions of the antibiotic. When the MIC is decreased, it creates a selective
force for the development of resistant genotypes at lower antibiotic
concentrations than otherwise.
These combined effects suggest that we should broaden our view of
the environmental contributors to the evolution of antibiotic resistance,
and rethink risk evaluation protocols and regulations for herbicides and
pesticides.Moreover, chemicals inﬂuencinghealth via effects on ourmi-
crobiota can come from various sources. Sewage sludge is treated and
then applied to agricultural land. After application of treated sludge to
soil there was a high risk of contamination by residual estradiol, antibi-
otics, caffeine, triclosan and triclocarban (Verlicchi and Zambello, 2015).
Thuswe need to evaluate the impacts of doses of chemicals that occur in
the real world, and we must also test long-term effects of exposure to
low doses and to combinatorial effects. Attention must be given to the
comparability of methodology in order to avoid confounding factors
that could lead to inconsistent results (Koskinen et al., 2016). On the
basis of various observationsmade in this paper, effects on themicrobi-
ota, in particular on its biodiversity and functionality, should be in-
cluded in these evaluations.
8.1. Glyphosate
One agrochemical that deserves special mention is glyphosate for
which there are conﬂicting reports regarding its hazards for human
health (Tarazona et al., 2017). This commonly used herbicide inhibits
the enzyme 5-enolpyruvylshikimate-3-phosphate synthase. Since
mammals lack this enzyme, glyphosate was thought to be harmless to
humans. However, manymicroorganisms do have enzymes that are af-
fected by glyphosate, and glyphosate formulations have been patented
as antibacterial compounds (Abraham and Monsanto Technology Llc,
2010). Therefore, we have to consider whether glyphosate is causing
signiﬁcant changes to soil, plant, animal and human microbiota, and if
so, whether these changes are damaging to our health (Cuhra et al.,
2016). For example, the shikimate pathway, when present in bacteria,
is involved in the synthesis of aromatic compounds like tyrosine and
tryptophan that are key intermediaries in systemic effects of ourmicro-
biota (see previous section in this review). Tested in vitro, and at rela-
tively high concentrations, glyphosate formulations had more
deleterious effects on beneﬁcial bacteria from chickens and cattle than
on pathogenic ones, though it was not clear why this occurred (Kruger
et al., 2013; Shehata et al., 2013). Similarly, other experimental work
has revealed additional potentially harmful mechanisms and effects,
but it is not clear whether these involve concentrations that occur in
human communities. While still speculative, the potential effects of
this widely used herbicide on the environmental and internal microbi-
ota warrant further investigation (Cuhra et al., 2016; Vandenberg et
al., 2017).
For example, In addition to some speciﬁc actions of glyphosatemen-
tioned above, this molecule and commercial formulations of it are re-
ported to act as endocrine disruptors (reviewed in Mnif et al., 2011).
Beside various endocrine-related disturbing effects in vertebrates and
invertebrates, numerous epidemiological correlations have been made
between exposure to different pesticides and occurrence of endocrine-
dependent cancers or other disturbances of endocrine-dependent func-
tions in humans (Mnif et al., 2011). In some of the studied cases,correlations are also foundwith dysfunctions of the immune and central
nervous systems,which could suggest effects on the systemic inﬂuences
of the microbiota.
9. Conclusions
A large body of evidence suggests that our microbiome, that some
authors consider as our “second” or “third genome” (~100 times more
genes than our primary genome), plays key roles in the developmental
phase of eukaryotes and potentially in that of their progeny (Miller Jr,
2016). The microbiota is at the interface between the environment
and our internal world (Fig. 1), can adapt itself and its hosts to different
and changing environments, and may contribute towards a good
OneHealth/EcoHealth relationship between our body and the external
environment. We summarize our suggestions for further research in
Table 1, while in the following paragraphs we consider other aspects
of policy and planning.
9.1. Microbiota research and policy in the EU
At the international level, large research consortia have been created
to study themicrobial genome in relation to health, notably the Interna-
tional Human Microbiota Consortium (IHMC, 2008). At the EU level,
transnational projects Metacardis and MyNewGut (Metacardis, 2012;
My New Gut, 2013) aim to study the relationship between microbiota
and health (withmulti-omicsmethods) and to reveal how themicrobi-
ota changes with different pathologies and lifestyle factors, including
diet, drug therapies, hygiene practices, travel, and disease. These pro-
jects involve large samples sizes, and the creation of biobanks and
meta-datasets (workshop presentation by Dao, 2016; workshop poster
by Sanz, 2016). A workshop was held in Belgium in 2016, co-organized
by OCDE and EWI (Department Economy, Science and Innovation of the
Flemish Government). This aimed to identify gaps in our understanding
at the scientiﬁc and regulatory levels in order to facilitate progress in the
microbiota ﬁeld, and to contribute to an innovative bioeconomy sector
developing preventive medical interventions that target the gut micro-
biota (workshop presentation by D'Hondt, 2016a, b). It discussed
existing consortia and initiatives at the international and European
levels.
9.2. Interdisciplinary transnational research and intersectoral policies
To increase understanding of all components of external and inter-
nal microbiota-host interactions and their implications for human
healthwe need interdisciplinary and transboundary studies. Specialized
medical doctors and veterinarians (including oncologists, neurologists,
(neuro-)gastroenterologists, endocrinologists, diabetologists,
allergologists, pneumonologists, rheumatologists, psychiatrists) and
other health care professionals (nutritionists, food hygiene specialists,
psychologists), should collaborate with (micro-)biologists, immunolo-
gists, ethologists, anthropologists, zoologists, biotechnologists, bio-
informaticians, engineering specialists, and of course botanists, environ-
mentalists, ecologists, phytopathologists, and agronomists. In addition,
ethologists, anthropologists, socio-psychologists, and generalistmedical
doctors should be involved, as well as architects and political scientists.
Such inter- and trans-disciplinary approaches may provide knowl-
edge that will enable us to use microbiota composition as an indicator
of related present or future health issues. Similarly, this knowledge
will enable the exploitation of microbes or their products as preventive
or therapeutic strategies. Such strategies may involve interventions re-
lated to food, pharmaceuticals and the environment, and targeting
chronic diseases at the population level or in at risk subgroups. By eas-
ing the ﬁnancial burden of such diseases this knowledge could contrib-
ute to the economy as well as to public health. It could simultaneously
provide human health data to support progress towards sustainable
Table 1
(Part 1) urgent research goals.
A. Further research to better understand and exploit the symbiotic relationship
between microbiota and host
• what constitutes a “healthy” or “health-promoting” microbiota composition?
• what is the inﬂuence on the human microbiota of:-
- genetics, age, season, geographic location and local parameters affecting
symbiotic evolution?
- quality of the living environment (natural environments, biodiversity, pol-
lution etc.)?
- food production systems, diet and lifestyles?
- exposure by various routes to a range chemical substances, additives and
xenobiotics?
• can we develop population level microbiota monitoring?
• how can we use knowledge of the microbiota in the management/prevention
of diseases?
B. Recognizing the full spectrum of the beneﬁcial effects of a “health-promoting”
microbiota. Understanding the interactions of the internal microbiota with the
host
• characterize effects on human and animal health and disease of
- microbiota components
- bioactive metabolites produced by microbiotas
• identify changes in microbiota associated with
- a wide range of diseases
- predisposition to disease in prospective studies.
• explore
- physiological pathways involved in interactions of microbiota with the host,
and the dynamics of these effects
- using the microbiota as a disease risk diagnostic and prognostic tool
- using microbes or derived host-microbe metabolites as disease preventive
approaches or treatments
- mechanisms of adaptive co-evolution potentially brought by the microbiota
to their host, and their relationship with health outcomes
C. Putting microbiota research in the broader environmental-ecological context
• Characterize
- the short and long term inﬂuence of the environmental microbiota on the
human microbiota
- unrecognized routes of human exposure to microbiota in the environment
- the effect of contact with nature, particularly in urban contexts, on our
microbiota
- the effect of the built environment and materials on our microbiota
- the inﬂuence of the external microbiota on our internal microbiota
- the load (time and magnitude) of external microbiota exposures necessary
to change our microbiota
- the links between such microbiota changes and health parameters
- microbial species interactions outside and within human body
- exterior and internal microbial diversity
• More generally, evaluate the role of the microbiota in the impacts of nature on
various dimensions of human health, and the interlinkages between those
impacts.
D. Characterizing the effects of food production systems, food, diet & nutrition, and
lifestyle (e.g. stress) on our microbiota
• Explore/compare effects on the human microbiota of:-
- food produced by conventional agriculture and by agroecological systems
- different varieties and breeds utilized (modern, traditional).
- industrialized foods/food components & additives compared to more tradi-
tional diets
- interactions with other factors of the modern life style (e.g. stress, low
physical activity, etc.)
- diets rich in vegetables versus animal products.
• Ensure that plant and animal breeding strategies reﬂect the importance of
microbial diversity for natural resistance to disease and pathogens
E. Study the impact of chemical substances (drugs, pesticides, additives, endocrine
disruptors) on human microbiota and health; study their combinatorial effects
• Explore the impact of current antibiotics on:-
- the general environmental and internal microbiota
- “defensive microbes”, and related health impacts on infectious and NCDs
• Resituate the resulting knowledge in the current world problem of antibiotic
resistance (see session of the workshop: Cross-pollinating agro-eco-human
health)
• Investigate potential effects on health parameters and the microbiota of:-
- non-dose related impacts of endocrine disruptors and other xenobiotics and
chemicals
- ampliﬁed impacts on the endocrine system and (directly or indirectly) on
Table 1 (continued)
A. Further research to better understand and exploit the symbiotic relationship
between microbiota and host
other physiological functions
- glyphosate (and its commercial formulations and compounds), currently
the most used herbicide at the planetary level, on our microbiota and con-
sequent impacts on our health
- early life exposure to various environmental pollutants
- chronic exposure to low doses vs acute exposure to high doses
- transgenic foods
• Re-evaluate molecules which are considered safe (e.g. additives for food,
drugs, cosmetics) to identify effects on human microbiota and health
• Generate additional data and tools for risk assessment and, thereby, inform
existing regulations, in particular European Union legislation, on:-
- effects on microbiota of pesticides (declared active molecules and commer-
cial formula) and endocrine medicine wastes and disruptors: explore
potential relationships with current and increasing NCDs
- additives: explore their effects on the microbiota and potential links with
NCDs.
- combinatory effects of various of these substances (among other pesticides
+ antibiotics, in the evolution of antibiotic resistance).
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styles and urban environments.
Education should prepare future scientists for inter- and transdisci-
plinary work and enhance their capacity to listen to, understand, com-
municate and put in place ways of thinking and approaches to
problem solving, that are essential for collaboration across disciplines.
While scientiﬁc specialization is useful and at present unavoidable, spe-
cialists should be trained to understand the bigger picture. The curricu-
lum of studies in universities should be adjusted accordingly.
A huge budget has been allocated to studies on themicrobiota in the
USA (Handelsman, 2016). This is not the case in the EU.We call upon EU
policy makers to reinforce integration of the relevant policy sectors
(health, environment, agriculture, land use planning, housing, food se-
curity and nutrition) in order to generate support for ﬁnancing interdis-
ciplinary microbiota research. There is also an urgent need to support
longitudinal population-wide studies tomonitor the drivers of the tran-
sition from health to disease and the underlying biological processes af-
fecting host-microbiota cross-talk. Such studies could generate
collections of microorganisms (biobanks) that could be exploited to
characterize a healthy microbiota, to identify normal variation and dy-
namics of adaptation to changes in the environment, and to characterize
speciﬁc functional microbes and their products. Such research will also
set the baseline for standardization of collection, storage and analysis of
samples and data. This will lead to the required identiﬁcation of bio-
markers corresponding to health or disease, and of clinical endpoints
that can be used for early prediction, diagnosis and prognosis of disease,
and for validating the efﬁcacy of preventive and therapeutic
interventions.9.3. Changing behavior among the public, health professionals and other
professional sectors
On the basis of current knowledge, unsoundly exaggerated hygiene
measures in daily life should be reconsidered, while strict hygiene prac-
tices in clinical settings remain essential. We have to move to more
“targeted hygiene”, focusing on routes of transmission and on sites
where pathogens accumulate, especially at the start of epidemics
(Stanwell-Smith et al., 2012). It should be emphasized that hygiene is
not a major cause of disruption of our exposures to appropriate micro-
bial inputs. Accumulated data suggest that the general impoverishment
of the biodiversity of our microbiota and the consequent deleterious
health impacts aremainly due to antibiotic use (especially in pregnancy
and early life), the western diet, caesarian birth, lack of breast feeding,
and reduced exposure to the natural environment (Haahtela, 2014;
Logan et al., 2015; Rook et al., 2014a; von Hertzen and Haahtela,
Table 2
Sustainable Development Goals of the United Nations Agenda 2030.
Sustainable Development Goals (SDG)
SDG 1 End poverty in all its forms everywhere
SDG 2 End hunger, achieve food security and improved nutrition and promote
sustainable agriculture
SDG 3 Ensure healthy lives and promote well-being at all ages
SDG 4 Ensure inclusive and equitable education and promote lifelong learning
opportunities for all
SDG 5 Achieve gender equality and empower all women and girls
SDG 6 Ensure availability and sustainable management of water for all
SDG 7 Ensure access to affordable, reliable, sustainable and modern energy for all
SDG 8 Promote sustained, inclusive and sustainable economic growth and decent
work for all
SDG 9 Build resilient infrastructure, promote inclusive and sustainable
industrialization and foster innovation
SDG
10
Reduce inequality within and among countries
SDG
11
Make cities and human settlements inclusive, safe, resilient and
sustainable
SDG
12
Ensure sustainable consumption and production patterns
SDG
13
Take urgent action to combat climate change and its impacts
SDG
14
Conserve and sustainably use the oceans, seas and marine resources for
sustainable development
SDG
15
Protect, restore and promote sustainable use of terrestrial ecosystems,
sustainably manage forests, combat desertiﬁcation, and halt and reverse
land degradation and halt biodiversity loss
SDG
16
Promote peaceful and inclusive societies for sustainable development,
provide access to justice for all and build effective, accountable and
inclusive institutions at all levels
SDG
17
Strengthen the means of implementation and revitalize the global
partnership for sustainable development
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2016).
Policy makers should also support education of the public and con-
cerned professionals about the new insights into the functioning of
microbiotas and the newopportunities this is creating for novel applica-
tions and behaviors supporting better health and wellbeing. The public
should be helped to understand this new paradigm, in which health is
addressed in a holistic way including host-microbiota interactions,
and they should understand the role this approach could play in the
global challenge of non-communicable diseases, and act accordingly.
Socio-psychologists could help to integrate this societal change of para-
digm not only into understanding but into practice.
While we clearly need to affect the way of thinking of the public, we
also need to avoid exaggerated, sensational, and scientiﬁcally unsound
press coverage, announcingmiracles that could be accomplished thanks
to the microbiota. Similarly, misguided press announcements suggest-
ing a general reduction of hygiene practices should be particularly
avoided in this period where various societal changes and rapid travel
favor the emergence and diffusion of pathogens (Workshop Session,
2016c). We also need to consider other drivers that affect the behavior
of humans towards exposure to environmental microbiota. For exam-
ple, there are health programmeswhich inform about the risk of disease
when in contact with nature; these include those spread by ticks and
other vectors. Researchers, authorities and policy makers should make
recommendations which take these controversies into account and ex-
plain their relationship, and highlight the beneﬁcial aspects of contact
with microbiota.
The Global Partnership for Business and Biodiversity
(CBD_biodiversity, 2017) initiated by the international CBD (Conven-
tion on Biodiversity) since its COP-10 meeting, and completed by com-
mitments for actions at its COP-13 meeting (end 2016) should
encourage that partnership for co-responsibility towards biodiversity
and its ecosystem services, including those of the microbiota towards
human and environmental health. The microbiota should of course be
included among the indicators developed by the “Initiative for Biodiver-
sity Impact Indicators for Commodity Production” in the framework of
that partnership (CBD_Commodity production, 2017). Related behav-
ioral changes and initiatives by business, coupled to changes in public
demand and help from public services, could promote faster societal
changes in lifestyle.
9.4. Contact with the natural environment: a disease prevention strategy
supported by UN
These insights suggest that we need to encourage the responsible
authorities to promote access to, and contact with nature (Rook,
2013). The knowledge collected here places the environmentalmicrobi-
ota as an important concrete element in the health beneﬁts that contact
with the natural environment can provide. In particular, for young chil-
dren raised in urban areas there should be access to parks, squares, gar-
dens, urban farms and other green infrastructures like green walls and
roofs. The interior public space (schools, hospitals, work places) should
be also enhanced in this regard. Integration of green infrastructures into
urban planning could be a simple and cost-effective way to ensure that
the living environment contributes to the healthy microbiota (work-
shop presentation by Furman, 2016). Consistent with the OneHealth/
EcoHealth approach, healthy ecosystemsmay be key to disease preven-
tion and should be viewed as a fundamental pillar of a cost-effective
healthcare strategy (von Hertzen et al., 2015).
The United Nations has set sustainable management of our planet's
natural resources, as a prerequisite for social and economic develop-
ment in its General Assembly of September 2015, adopting Agenda
2030 for sustainable development, described in point 33 of the online
document (UN General Assembly, 2015). A request for implementing
Agenda 2030 is to take into account the interlinkages of the various
SDGs (Sustainable Development Goals) and to implement them in anintegrated manner. Among the SDGs of UN Agenda 2030 (see Table
2), reaching Goal 3 (that includes reduction of communicable and
non-communicable diseases) can be facilitated by practices enhancing
diverse microbiota. Moreover, implementation of knowledge of the
microbiome, improved by complementary research, could obviously
contribute to integrated realization of several SDGs. Taking into account
the knowledge compiled in this review, it could indeed participate in
Goal 2, Goal 6, Goal 11, Goal 14, and Goal 15 (Table 2). Moreover,
through inﬂuence on the previous ones, implementation of other
SDGs could be helped (Goal 1; Goals 8 and 9; Goal 10; Goal 13). On
the other hand, there are SDGs that could help to materialise these
goals, such as Goal 4 and Goal 17. Implementing the conceptual frame-
work of UN Agenda 2030, cross-sectoral research on the lifestyle-natural
environment-microbiota-health nexus should be supported. Such support
could contribute signiﬁcantly when national, regional and global poli-
cies, as well as local practices, such as land use planning, are being de-
veloped and decided upon. Taking also into account the request of
universality of Agenda2030, the role of microbiota in reaching SDGs is
important in several regions of the world; in respect of sustainable de-
velopment, all countries are developing countries.
Finally, access to a safe, healthy and ecologically-balanced environ-
ment as a human right has been addressed in recent UN meetings. At
the 34th session of the Human Rights Council of the General Assembly
of the UN (27 February–24 March 2017), the Special Rapporteur trans-
mitted a report on human rights obligations relating to the conservation
and sustainable use of biological diversity. It was suggested that full en-
joyment of human rights requires ecosystem services provided by bio-
diversity that promote healthy food and water and a safe, clean,
healthy, sustainable environment (Special Rapporteur, 2016). Microbial
diversity was explicitly mentioned in this report, as were the links be-
tween environmentalmicrobiodiversity and our immunoregulatory cir-
cuits, and the increasing incidences of NCDs in all parts of the world.
These increases result, at least in part, from loss of microbial diversity
(Haahtela et al., 2015; Hanski et al., 2012; Rook, 2013). In its conclusions
and recommendations, this report calls for the States to ensure that
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adopted a Strategic Plan) implementing the CBD 2011–2020 Strategic
Plan reﬂect the necessary scope and ambition (now including a
human rights perspective linked to health) to protect biodiversity. Ap-
plication of current knowledge on microbiota diversity to improve
health should thus now be considered as a policy obligation providing
Parties to the UN adopt this report. Research on the environment-micro-
biota-health axis could contribute signiﬁcantly to the implementation of
“good practice” guidelines and to increased understanding and aware-
ness of the links between human rights and protection of biodiversity
in the general environment.
As a conclusion and as follow-up to the Environmental and internal
Microbiota session of the European OneHealth/EcoHealth workshop
2016 (Workshop Session, 2016b), we suggest in Table 3 howwe should
prioritize research on the environment-microbiota-health axis with a
view to promoting preventive healthcare in national, EU and globalTable 3
Research and science-policy relationships on the lifestyle-natural environment-microbiota-
health axis.
Prioritize research and science-policy relationships with a view to promoting
preventive healthcare in national, EU and global policies: for humans, plants and
animals (ecosystems), in an EcoHealth interrelated approach, involving potential
necessary changes in lifestyles and societal habits
• Deﬁne a “healthy” microbiota and its role in resilience to NCD development
o Composition at the species level, and overall metabolome
• Explore food production and the microbiota in the context of human/animal/-
plant health.
o are there (signiﬁcant) differences between the systems (conventional
agriculture, organic farming and other agroecological approaches) in this
regard?
o which system offers the most cost-effective approach?
o which practices should be mandated from a public health point of view?
o can food products that target the gut microbiota compensate for a bad
microbiota heritage?
• Explore the impacts of nature on the microbiota
o effects on human health, mediated via the microbiota, of disturbance of
ecosystems
o effects on the microbiota of spaces or processes which enable good health.
o what qualities of green infrastructures in cities enhance human microbiota
in ways that beneﬁt health?
• Explore the effects of environmental components and substances/xenobiotics on
the external and internal microbiota and the relationship to health (NCDs &
infectious diseases; see Table 1), with a view to legislative amendments to risk
assessment requirements
o antibiotics:
- make the link with the world problem of current antibiotics abuse and anti-
biotic resistance
- make the relationship with clinical practice and the food chain (use of anti-
biotics during husbandry of livestock and honeybees) and human health
- assess the risk of developing more infectious diseases but also more NCDs in
the long term.
o additives, including those presently considered safe
o pesticides (declared active molecules and commercial formula), endocrine
medicine waste and endocrine disruptors
o combinatory effects of various of these substances on the microbiota, and
bidirectional interactions between environmental pollutants and our
microbiota, to relate to (potential) amplifying and combinatory negative
effects of pollutants on health
• Explore the molecular mechanisms underlying all these effects.
• Explore mechanisms that enable a transition in lifestyles towards paths which
build on a sustainable natural environment-microbiota-health nexus
• Establish a science-policy platform in an integrated policy approach to facilitate
the translation of research ﬁndings into:-
o policy making processes and applications at the national, EU and interna-
tional levels
o health policy (including disease prevention through food)
o land management policies (for agriculture, forestry, industrial develop-
ment)
o urban planning policies (sustainable urban development)
o educational policies (from daycare to academic)
o nature conservation policies (e.g. EU Green Infrastructure strategy), includ-
ing marine naturepolicies for humans, plants and animals. We highlight an integrated ap-
proach where the microbiotas of living organisms and of the environ-
ment are important signaling transducers of the communication
system that connects all elements of the global ecosystem. As such,
the contributions ofmicrobiotas to the health andwell-being of humans
are of paramount importance.
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